AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 79 filers reported holding AKEBIA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $221,000 | -69.6% | 40,035 | -45.1% | 0.02% | -70.5% |
| Q2 2018 | $727,000 | -34.4% | 72,879 | -37.4% | 0.06% | -22.8% |
| Q1 2018 | $1,109,000 | +118.7% | 116,416 | +241.4% | 0.08% | +75.6% |
| Q4 2017 | $507,000 | +79.8% | 34,101 | +137.7% | 0.04% | +60.7% |
| Q3 2017 | $282,000 | -24.8% | 14,346 | -45.0% | 0.03% | -33.3% |
| Q2 2017 | $375,000 | +85.6% | 26,063 | +18.7% | 0.04% | +110.0% |
| Q1 2017 | $202,000 | +11.0% | 21,954 | +25.5% | 0.02% | -20.0% |
| Q4 2016 | $182,000 | +15.2% | 17,500 | 0.0% | 0.02% | +19.0% |
| Q3 2016 | $158,000 | -82.7% | 17,500 | -85.7% | 0.02% | -82.6% |
| Q2 2016 | $915,000 | -18.7% | 122,326 | -2.1% | 0.12% | -11.0% |
| Q1 2016 | $1,126,000 | +110.5% | 125,001 | +201.9% | 0.14% | +103.0% |
| Q4 2015 | $535,000 | – | 41,400 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 4,652,561 | $3,340,000 | 5.66% |
| Orchard Capital Management, LLC | 1,762,731 | $1,265,000 | 0.36% |
| Ikarian Capital, LLC | 1,200,000 | $860,000 | 0.11% |
| Ikarian Capital, LLC | 800,000 | $575,000 | 0.08% |
| XTX Topco Ltd | 102,392 | $74,000 | 0.03% |
| Nantahala Capital Management | 965,800 | $693,000 | 0.03% |
| Worth Venture Partners, LLC | 63,500 | $46,000 | 0.02% |
| Ardent Capital Management, Inc. | 43,429 | $31,000 | 0.02% |
| Virtus ETF Advisers LLC | 65,149 | $47,000 | 0.02% |
| RICE HALL JAMES & ASSOCIATES, LLC | 513,292 | $368,000 | 0.02% |